By 2050, almost 1 billion people are expected to live with osteoarthritis-a disabling musculoskeletal condition with currently no cure. Despite its burden and costs, osteoarthritis remains largely invisible in national and global health agendas, is poorly integrated within service models for other chronic health condit...
Andrew M. Briggs, J. Bowden, M. Risberg et al.· The Lancet· 0 citations
Osteoarthritis is a major degenerative joint disease often triggered by traumatic injuries, yet current treatment options remain limited in restoring cartilage integrity. Mesenchymal stromal cells (MSCs) represent a promising source for chondrogenic regeneration, but their differentiation potential may vary according t...
C. C. Zuliani, I. I. Damas, Kleber Cursino de Andrade et al.· Journal of Molecular Histolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.